drugset / Trial / NCT00597896
Cognitive Enhancement in Bipolar Disorder
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to examine whether the medication pramipexole (Mirapex) may be able to improve cognitive problems (i.e. difficulties with thinking, memory, and concentration) that may be associated with bipolar disorder.
Timeline
- Start
- 2005-10
- Primary completion
- 2011-04
- Completion
- 2011-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pramipexole | Unknown | 0.75 mg | Oral |